Modification in mucin O-glycosylation causes a disruption of host–microbe interactions and mucosal immunity, contributing to a compromised intestinal barrier and associated diseases such as inflammatory bowel diseases (IBD)11,20–22. This evidence concerns the gene MUC5AC and inflammatory bowel disease.